Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Adenosine receptor mediates motility in human melanoma cells
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adenosine receptor mediates motility in human melanoma cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Motility
100%
Adenosine
100%
Human Melanoma Cells
100%
Adenosine Receptors
100%
Melanoma Cells
66%
Cell Motility
66%
Chemotaxis
66%
Pertussis Toxin
66%
Adenosine Receptor Antagonists
66%
Chemotactic Response
66%
Adenosine nucleotides
66%
Adenine nucleotides
66%
Tumor Cells
33%
Complementary DNA (cDNA)
33%
Cell-mediated
33%
Receptor Activity
33%
Tumor Progression
33%
Paracrine
33%
Chinese Hamster Ovary Cells
33%
Tumor Metastasis
33%
Number of Factors
33%
Adenosine A1 Receptor
33%
Adenosine Receptor Agonists
33%
A1 Subtype
33%
Antimetastatic Therapy
33%
Exogenous Factors
33%
A2058
33%
Medicine and Dentistry
Melanoma Cell
100%
Adenosine
100%
Adenosine Receptor
100%
Cell Migration
40%
Cell Motility
40%
Pertussis Toxin
40%
Adenosine Phosphate
40%
Adenosine Receptor Antagonist
40%
Chemotaxis
40%
Adenine Nucleotide
40%
Tumor Progression
20%
Metastatic Carcinoma
20%
Tumor Cell
20%
Complementary DNA
20%
Adenosine A1 Receptor
20%
Chinese Hamster Ovary Cell
20%
Adenosine Receptor Agonist
20%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Adenosine
100%
Adenosine Receptor
100%
Adenosine Phosphate
40%
Pertussis Toxin
40%
Adenine Nucleotide
40%
Adenosine Receptor Blocking Agent
40%
Neoplasm
20%
Metastasis
20%
Tumor Growth
20%
Complementary DNA
20%
Chinese Hamster
20%
Adenosine A1 Receptor
20%
Adenosine Receptor Stimulating Agent
20%
Neuroscience
Adenosine Receptor
100%
Adenosine
83%
Adenosine Monophosphate
33%
Cell Migration
33%
Receptor Antagonist
33%
Cell Motility
33%
Chemotaxis
33%
Pertussis Toxin
33%
Adenine Nucleotide
33%
Complementary DNA
16%
Receptor Agonists
16%
Adenosine A1 Receptor
16%